Purchase Order 36C24622P0046
Award Date
10/7/21
Potential Completion Date
10/6/25
Potential Value
$51K
Federal Agency
Veterans Integrated Service Network 6
Awardee
Biotheranostics Inc.
Ultimate Awardee
Hologic, Inc.
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $256,599.00 firm fixed price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 17 to Biotheranostics Inc., a self-certified small disadvantaged business and division of Hologic, Inc. The contract is for the provision of the Breast Cancer Index (BCI) diagnostic test. The BCI test leverages genomic analysis to aid in cancer screening, diagnosis, and treatment planning. This award is not set aside and is one of several prime federal...
This $139,428.00 firm fixed price purchase order was awarded by the Defense Health Agency (DHA) to Biotheranostics Inc., a self-certified small disadvantaged business. The contract is for the provision of Biotheranostics' proprietary Breast Cancer Index genomic diagnostic testing services to support cancer care for the DHA's beneficiary population. This contract award represents one of several prime federal awards, totaling over $700,000 between 2021-2023, that Biotheranostics has received...
The U.S. Defense Health Agency (DHA) has awarded a $139,428 firm fixed price purchase order to Biotheranostics Inc., a self-certified small disadvantaged business, to provide Breast Cancer Index testing services. This award, with a completion date of September 25, 2024, is not set aside and supports the DHA's efforts to enhance cancer care for veterans and service members through advanced molecular diagnostics that guide treatment planning. Biotheranostics, a division of Hologic, Inc., has...
This federal contract award to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, is for the provision of the company's Oncotype DX portfolio of cancer diagnostic assays. The contract, valued at $200,327.28, was awarded by the Veterans Integrated Service Network 6 (VISN 6) of the U.S. Department of Veterans Affairs (VA). It is a firm-fixed-price purchase order with a period of performance through September 30, 2025. The contract does not utilize a set-aside designation, as Genomic...
This is a firm fixed-price BPA call order awarded by the Department of Veterans Affairs (VA) to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract, valued at $3,453.96, is for the provision of express cancer testing services, specifically Oncotype DX assays, to support the VA's healthcare programs. Genomic Health, as a provider of genomic-based cancer diagnostic tests, has received numerous prime and subcontractor awards from various federal agencies, including the...
This contract award to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, is for the provision of Oncotype genetic testing services to the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 22. The $114,305 Blanket Purchase Agreement (BPA) call covers a performance period through February 2026 and allows the VA to order cancer screening, treatment selection, and disease monitoring testing services on an as-needed basis. Genomic Health is also the prime...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price definitive contract to Genomic Health, Inc., a subsidiary of Exact Sciences Corp, to provide BREAST ONCOTYPING services. The contract has a potential value of $284,413.16 and a period of performance ending on September 30, 2022. Genomic Health, Inc. has provided cancer testing services, including its Oncotype DX portfolio of assays, to various Department of Defense and VA medical facilities under past...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a $226,115.40 firm fixed price delivery order to Genomic Health, Inc., a subsidiary of Exact Sciences Corp, for Genomic Oncotype breast, colon, and prostate cancer testing services. This order was placed under Genomic Health's existing Multiple Award Schedule contract for Medical Laboratory Testing and Analysis Services. Genomic Health has a history of providing cancer testing...
This is a firm fixed-price contract awarded by the Department of Veterans Affairs Veterans Health Administration to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for the provision of proprietary genetic testing services for cancer diagnosis and treatment selection. The contract was issued as a Blanket Purchase Agreement (BPA) call order under Genomic Health's existing General Services Administration (GSA) Medical Laboratory Testing and Analysis Services schedule contract. The...
This federal contract award to Biodesix, Inc., a for-profit medical laboratory and diagnostic testing company, was issued by the U.S. Department of Veterans Affairs (VA) to provide Nodify lung blood testing services. The $2,500 firm fixed-price delivery order contract has a completion date of September 30, 2024, and is not set aside for any special designation. Biodesix has been awarded multiple VA contracts for specialized lung testing services, including Nodify lung blood testing, STX lung...